Oblenio Bio
Pre-clinicalOblenio Bio aims to transform the treatment of severe autoimmune diseases, putting the promise of immune reset in reach for millions of patients.
Founded
2021
Focus
AntibodiesBiologics
About
Oblenio Bio aims to transform the treatment of severe autoimmune diseases, putting the promise of immune reset in reach for millions of patients.
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile